[list_product_images]|Figure 1. IHC analysis of KRT19 using anti-KRT19 antibody (PB9715).
KRT19 was detected in a paraffin-embedded section of human colon cancer tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1052) with BCIP/NBT (Catalog # AR1023) as the chromogen.|Figure 2. IHC analysis of CYCS using anti-CYCS antibody (PB9334).
CYCS was detected in a paraffin-embedded section of human rectal cancer tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1052) with BCIP/NBT (Catalog # AR1023) as the chromogen.|Figure 3. IHC analysis of CYCS using anti-CYCS antibody (PB9334).
CYCS was detected in a paraffin-embedded section of human lung cancer tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1052) with BCIP/NBT (Catalog # AR1023) as the chromogen.|Figure 4. IHC analysis of Catenin-β using anti-Catenin-β antibody (BA0426).
Catenin-β was detected in a paraffin-embedded section of human rectal cancer tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1052) with BCIP/NBT (Catalog # AR1023) as the chromogen.[/list_product_images]